Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Headache Pain. 2010 Apr;11(2):175-8. doi: 10.1007/s10194-010-0193-4. Epub 2010 Feb 9.

A pilot study of topiramate dosages for migraine prophylaxis in an Asian population.

Author information

  • 1Department of Neurology, National Neuroscience Institute, Singapore General Hospital, Outram Road, Singapore, Singapore. gnrlyl@sgh.com.sg

Abstract

Topiramate is known to be efficacious in migraine prophylaxis, but its optimal dose has not been systematically studied in the Asian population. Here, we show that a fixed low dose of topiramate 25 mg/day is efficacious in migraine prophylaxis and also attest to advantages in terms of medication cost savings and more favourable side effect profile.

PMID:
20143246
[PubMed - indexed for MEDLINE]
PMCID:
PMC3452284
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer Icon for PubMed Central
    Loading ...
    Write to the Help Desk